The Gross Margin of Adc Therapeutics Ltd (ADCT) is
92.87%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2025-12-31 |
92.87%
|
| 2024-12-31 |
91.60%
|
| 2023-12-31 |
96.36%
|
| 2022-12-31 |
99.00%
|
| 2021-12-31 |
95.87%
|
| 2020-12-31 |
95.89%
|
| Ticker |
Name |
Value |
|
GNRO.PA
|
Geneuro SA
|
7775.20%
|
|
IDIA.SW
|
Idorsia Ltd
|
90.52%
|
|
MYOV
|
Myovant Sciences Ltd
|
77.68%
|
|
OBSV
|
Obseva SA
|
7775.20%
|
|
ACIU
|
AC Immune AG
|
7775.20%
|
|
ALVR
|
Allovir Inc
|
7775.20%
|
|
AMTI
|
Applied Molecular Transport Inc.
|
7775.20%
|
|
CGEM
|
Cullinan Therapeutics, Inc.
|
7775.20%
|
|
CCCC
|
C4 Therapeutics, Inc.
|
7775.20%
|
|
ZYME
|
Zymeworks Inc.
|
7775.20%
|
|
DCPH
|
Deciphera Pharmaceuticals Inc
|
97.72%
|
|
ALEC
|
Alector, Inc.
|
7775.20%
|
|
CYTK
|
Cytokinetics, Incorporated
|
7775.20%
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
7775.20%
|
|
MCRB
|
Seres Therapeutics, Inc.
|
7775.20%
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
7775.20%
|
|
RCUS
|
Arcus Biosciences, Inc.
|
7775.20%
|
|
RUBY
|
Rubius Therapeutics Inc
|
7775.20%
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
7775.20%
|
|
RLF.SW
|
Relief Therapeutics Holding SA
|
69.41%
|
|
BCAB
|
Bioatla Inc
|
7775.20%
|
|
BSLN.SW
|
Basilea Pharmaceutica AG Allschwil
|
83.08%
|
|
GBIO
|
Generation Bio Co
|
7775.20%
|
|
MOLN.SW
|
Molecular Partners AG
|
99.80%
|
|
DMTK
|
DermTech Inc
|
1.80%
|
|
INO
|
Inovio Pharmaceuticals Inc
|
60.13%
|
|
VECT
|
VectivBio Holding AG
|
7775.20%
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
7775.20%
|
|
PMVP
|
Pmv Pharmaceuticals, Inc
|
7775.20%
|
|
VBIV
|
VBI Vaccines Inc
|
-44.06%
|
|
CRSP
|
CRISPR Therapeutics AG
|
7775.20%
|
|
KRON
|
Kronos Bio LLC
|
7775.20%
|
|
KRYS
|
Krystal Biotech, Inc.
|
94.08%
|
|
KURA
|
Kura Oncology, Inc.
|
99.92%
|